Pilot Study of Cryoneurolysis to Reduce Pain and Opioid Use After Reverse Total Shoulder Replacement Surgery

What this Trial Is About

This research aims to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery RTSA. Cryoneurolysis uses cold to temporarily block a nerve in the shoulder. The study compares those who receive this treatment before surgery to those who do not, to see if it lowers pain and reduces the need for opioid pain medications after RTSA. The trial is a randomized controlled pilot study involving two groups one receiving cryoneurolysis of the suprascapular nerve before RTSA and one not receiving this treatment. Cryoneurolysis is applied pre-operatively to study its effect on pain control and opioid use. The study will measure outcomes over a 90-day period following surgery. Participants will be monitored through various assessments including opioid usage measured by morphine milligram equivalents, pain scores using the Pain Assessment Documentation Tool, shoulder range of motion evaluations, and patient-reported outcomes via the American Shoulder and Elbow Surgeons shoulder score. The study involves pre-operative treatment, surgery, and follow-up assessments over three months to evaluate safety and effectiveness.

Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)